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On Children 
And a woman who held a babe against her bosom said, "Speak to us of Children."  
And he said:  
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They are the sons and daughters of Life's longing for itself.  
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For even as He loves the arrow that flies, so He loves also the bow that is stable. 
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Abstract 
The Eph receptor tyrosine kinases and their ephrin ligands are cell surface molecules 
with a wide range of biological functions. Specifically, the Eph/ephrin receptor-ligand 
family influences cell behaviour during both embryogenesis and adult life, principally 
through modification of cytoskeletal organisation and cell adhesion. EphA1 (previously 
referred to as eph) was isolated during a search for novel tyrosine kinases with 
oncogenic potential. The murine homologue of hEphA1, formerly Esk and now
mEphA1, was cloned by reverse transcriptase PCR using degenerate oligonucleotide 
primers and RNA prepared from embryonic stem cells in culture. Northern blot analysis 
revealed expression in day 12 mouse embryo, and adult mouse thymus, liver, kidney, 
lung and placenta.  
The work in this thesis investigates the expression and function of EphA1 in mutant 
mouse and other animal models. This has been achieved by a number of different 
techniques including:- (1) the classical techniques of molecular biology; (2) a search for 
the zebrafish homologue of mEphA1; (3) generation and phenotypic analysis of the 
hPLAP EphA1 reporter knockout mouse and (4) generation of the EphA1 conditional 
knockout mouse.  
The chromosomal localisation and Southern blotting of genomic digests confirmed that 
Esk (mEphA1) is the murine homologue of eph (hEphA1). The binding of soluble 
mEphA1 to a panel of ephrin ligands analysed by surface plasmon resonance 
(BIACore), and the binding of various ephrin-Fc molecules to cell surface expressed 
EphA1, confirmed that EphA1 is the cognate receptor for the ephrin-A1 ligand. The 
mEphA1 genomic sequence was isolated, sequenced and the exon-intron boundaries 
mapped. Interestingly, Exon 3, which includes the ligand binding domain, is split into 
two smaller exons (Exon 3a and Exon 3b). This pattern was also found in hEphA1;
however, it is a novel finding compared with the other Ephs, and the reason underlying 
this difference remains speculative. In situ hybridisation analysis confirmed epithelial 
expression of mEphA1 in the basal layer of the epidermis, developing hair follicles, 
thymic epithelial cells and adult kidney. 
At the commencement of the zebrafish (ZF) library screening project in 1997, it seemed 
likely that there was an ZF orthologue of EphA1. However, over 50 clones were 
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isolated by degenerate PCR of zebrafish cDNA and genomic libraries, and although 
some of the sequences had homology to known Ephs, none matched EphA1. The ZF 
genome has now been sequenced completely [http://wwwmap.tuebingen.mpg.de/ ;
http://zfin.org/] and has confirmed that there is indeed no zebrafish orthologue of 
EphA1. 
The hPLAP EphA1 reporter knockout mouse was generated with the technical 
assistance of Dr Graham Kay (Queensland Transgenic Laboratory). The homozygous 
null mice have a kinky tail in two separate embryonic stem cell lines with a high degree 
of penetrance. A proportion of female null mice display the imperforate vagina 
phenotype. The null mice are otherwise grossly normal, with equal sex ratios and 
normal growth, health and life expectancy. The microscopic examination of 
haematoxylin and eosin stained sections of all the major organs revealed no histological 
abnormalities. The expression of hPLAP, (hence mEphA1), analysed in frozen sections 
confirmed the previous work which defined the epithelial expression of mEphA1 to the 
basal epidermis and hair follicle. There was also previously undescribed hPLAP 
(mEphA1) expression in the uterus, vagina and small intestine. 
The EphA1 conditional knockout mouse was also generated with the assistance of the 
Queensland Transgenic Facility. The homozygous null mice were grossly normal with 
equal sex ratio and normal health and life expectancy. The kinky tail phenotype was 
observed infrequently and has not yet been fully characterised in these mice. Similarly 
the imperforate vagina phenotype has not been observed in this strain of mice. This 
strain of genetically modified EphA1 knockout mice can be mated with various strains 
of Cre-deleter mice to achieve tissue specific silencing of EphA1 and consequently 
allow more precise analysis of EphA1 function. 
In summary, the studies described in this thesis have confirmed the importance of the 
Eph/ephrin receptor-ligands in both embryonic development and the maintenance of 
adult tissues, and have generated several new findings which add to our knowledge of 
the biology of EphA1. The generation of the hPLAP EphA1 reporter mice and EphA1 
conditional knockout mice has provided us with very useful tools. These knockout mice 
will allow further analysis of the role of EphA1 in mouse models of human diseases, 
including skin and colon cancer, severe sepsis and post-traumatic injury. 
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NIK  Nck interacting kinase 
NiV  Nipah virus 
NMDA N-methyl-D-aspartate 
NMJ  neuromuscular junction 
NMR  nuclear magnetic resonance 
N-WASP neuronal Wiskott Aldrich Syndrome protein  
OD600 optical density at wavelength of 600 nm 
OT  optic tectum 
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P5  post-natal day 5 
PAC  plasmid artificial chromosome 
PAK  p21-activated kinase 
pBst  pBluescript (Stratagene) 
PBS  phosphate buffered saline 
PCR   polymerase chain reaction 
PDGF  platelet derived growth factor 
PDZ Post-synaptic density protein-95, Drosophila disc large tumour 
suppressor (Dlg), Zona occludens-1 
PDZ-RGS3 PDZ - regulator of heterotrimeric G-protein signalling 
PEG  polyethylene glycol 
pfu  plaque forming units 
PH  pleckstrin homology (domain) 
PHIP  ephrin interacting protein 
PIX  p21-activated kinase interacting exchange factor 
PTP-BL phosphotyrosine phosphatase-basophil like 
PI3K   phosphatidylinositol 3-kinase 
Pick  protein kinase C interacting 
PIPES  piperazine-1,2-bis[2-ethanesulphonic acid]) 
PLC-R phospholipase CR
poly(A)+ polyadenylated ribonucleic acid 
PTB  phospho-tyrosine binding 
QIMR  Queensland Institute of Medical Research, Herston QLD 4029 
Q-PCR quantitative real-time polymerase chain reaction 
Ras-GAP Ras GTPase-activating protein 
RET  Ret proto-oncogene = “rearranged in transfection” 
RGC  retinal ganglion cell 
RhoGEF Rho associated guanine nucleotide exchange factor 
RNA  ribonucleic acid 
ROCK  Rho-associated kinase 
rpm  revolutions per minute 
RTK  receptor tyrosine kinase 
RT-PCR reverse transcriptase polymerase chain reaction 
SAM  sterile alpha motif  
SC  superior colliculus 
SCID  severe combined immunodeficiency 
SDF-1  stromal-cell derived factor 1 (CXCR4 ligand) 
SDS  sodium dodecyl sulphate 
SFK  Src-family kinase 
SH  Src homology (domain) 
Shh  sonic hedgehog 
SIRS  systemic inflammatory response syndrome 
SLAP  Src-like adaptor protein 
SOCS  suppressor of cytokine signalling 
SPF  specific pathogen free 
SSC  salt sodium citrate 
SSPE  salt sodium phosphate EDTA 
STAT  signal transducers and activators of transcription 
SVZ  sub-ventricular zone 
Taq Thermus aquaticus 
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TBE  tris-borate-EDTA 
TBS  tris-buffered saline 
TCF  T-cell transcription factor 
TE  tris-EDTA (10mM Tris, 1mM EDTA, pH 7.5) 
Tris  trishydroxymethylaminomethane  
Tris  2-amino-2-hydroxymethyl-1,3-propanediol. 
TsAP  thermosensitive alkaline phosphatase 
TN  temporal-nasal 
TNF  tumour necrosis factor 
TZ  termination zone 
TX-100 Triton X-100 
UTR  untranslated region 
UV  ultra-violet (light) 
VCAM vascular cell adhesion molecule 
VEGF  vascular endothelial growth factor 
WEHI  Walter and Eliza Hall Institute, Melbourne, Victoria 
WASP  Wiskott-Aldrich syndrome protein 
X. laevus Xenopus laevus 
ZF  zebrafish 
 

